Long-term survival after liver transplantation in 4,000 consecutive patients at a single center

Annals of Surgery

Volumn 232, Issue 4, 2000, Pages 490-500

  Jain, Ashok ^a,c   Reyes, Jorge ^a   Kashyap, Randeep ^a   Dodson, S Forrest ^a   Demetris, Anthony J ^b   Ruppert, Kris ^d   Abu Elmagd, Kareem ^a   Marsh, Wallis ^a   Madariaga, Juan ^a   Mazariegos, George ^a   Geller, David ^a   Bonham, C Andrew ^a   Gayowski, Timothy ^a   Cacciarelli, Thomas ^a   Fontes, Paulo ^a   Starzl, Thomas E ^a   Fung, John J ^a,e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

AGING; ARTICLE; FEMALE; GENDER; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SURVIVAL RATE;

ADOLESCENT; ADULT; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REOPERATION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033809515     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200010000-00004     Document Type: Article

References (41)

1. Experimental whole organ transplantation of the liver and of the spleen
2. Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow
3. Homotransplantation of the liver in humans
4. Evolution of liver transplantation
5. The Cambridge and King's College Hospital experience of liver transplantation, 1968-1983
6. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers
7. Liver transplantation with the use of cyclosporin A and prednisone
8. Liver transplantation under cyclosporine: A decade of experience
9. Ten years of liver transplantation: An evolving understanding of late graft loss
10. An analysis of late deaths after liver transplantation
11. Long-term results of pediatric liver transplantation: An analysis of 569 transplants
12. Liver transplantation in the United States from 1987-1998: Updated results from the Pitt-UNOS Liver Transplant Registry
13. Fifteen-year experience with adult and pediatric liver transplantation at the University of California, Los Angeles
14. Liver transplantation in Birmingham: Indications, results, and changes
15. The University of Toronto liver transplant program
16. Age and liver transplantation: A report of the Liver Transplantation Database
17. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data
18. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients
19. Influence of donor age on graft survival after liver transplantation - United Network for Organ Sharing Registry
20. Effect of donor age and sex on the outcome of liver transplantation
21. Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?
22. Retransplantation for late liver graft failure: Predictors of mortality
23. Single-center experience with primary orthotopic liver transplantation with FK506 immunosuppression
24. Conversion from cyclosporine to FK506 in liver allograft recipients with cyclosporine-related complications
25. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation
26. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
27. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation
28. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: Decreasing prevalence of irreversible hepatic allograft rejection
29. Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK506
30. Recurrent disease after liver transplantation
31. Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis
32. Hepatitis viruses and liver transplantation
33. Disease recurrence following liver transplantation
34. Successful liver transplantation after induction chemotherapy in children with inoperable, multifocal primary hepatic malignancy
35. Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies
36. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus
37. Early detection of de novo hepatitis C infection in patients after liver transplantation by reverse transcriptase polymerase chain reaction
38. Long-term outcome of hepatitis C virus infection after liver transplantation
39. Long-term outcome of hepatitis C infection after liver transplantation
40. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?
41. Long-term survival after retransplantation of the liver